Silver P J, Lepore R E, Cumiskey W R, Kiefer D, Harris A L
Department of Pharmacology, Sterling-Winthrop Research Institute, Rensselaer, New York 12144.
Biochem Biophys Res Commun. 1988 Jul 15;154(1):272-7. doi: 10.1016/0006-291x(88)90680-8.
Protein kinase C (PKC) activity in aortic and renal arterial smooth muscle from SHR (20-23 wk male; mean arterial pressure = 178 mm Hg) and WKY (age/sex matched; mean arterial pressure = 126 mm Hg) was quantitated. Activity was greatest in the particulate fractions relative to the soluble fractions in all sources. The only difference between SHR and WKY was in the soluble fraction from SHR renal arteries, which had 2 fold more activity (255 pmol/mg/min) when compared with WKY (136 pmol/mg/min). This difference was not apparently related to force modulation, since the magnitude of isometric force development in renal arteries in response to phorbol 12,13-dibutyrate was not different between SHR and WKY. The magnitude of force developed in response to phorbol 12,13-dibutyrate and PKC activity in the particulate fraction was greatest in aorta vs. renal arteries in both WKY and SHR. These results suggest that regional vascular differences in the amount of PKC activity may exist which are not apparently related to a disease state (i.e., hypertension). These differences may be related to differential sensitivity to phorbol ester-mediated contractions in isolated smooth muscle.
对自发性高血压大鼠(20 - 23周龄雄性;平均动脉压 = 178 mmHg)和WKY大鼠(年龄/性别匹配;平均动脉压 = 126 mmHg)主动脉和肾动脉平滑肌中的蛋白激酶C(PKC)活性进行了定量分析。在所有来源中,颗粒部分的活性相对于可溶性部分最大。自发性高血压大鼠和WKY大鼠之间的唯一差异在于自发性高血压大鼠肾动脉的可溶性部分,与WKY大鼠(136 pmol/mg/min)相比,其活性高2倍(255 pmol/mg/min)。这种差异显然与力的调节无关,因为在自发性高血压大鼠和WKY大鼠中,肾动脉对佛波醇12,13 - 二丁酸酯产生的等长力大小没有差异。在WKY大鼠和自发性高血压大鼠中,主动脉对佛波醇12,13 - 二丁酸酯产生的力大小和颗粒部分的PKC活性均高于肾动脉。这些结果表明,PKC活性量可能存在区域血管差异,这显然与疾病状态(即高血压)无关。这些差异可能与离体平滑肌对佛波醇酯介导的收缩的不同敏感性有关。